283 related articles for article (PubMed ID: 24929678)
1. Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel.
Dogan Onugoren M; Rauschka H; Bien CG
J Neuroimmunol; 2014 Aug; 273(1-2):115-6. PubMed ID: 24929678
[TBL] [Abstract][Full Text] [Related]
2. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic Lambert-Eaton Myasthenic Syndrome With Limbic Encephalitis: Clinical Correlation With the Coexistence of Anti-VGCC and Anti-GABAB Receptor Antibodies.
Cho JJ; Wymer JP
J Clin Neuromuscul Dis; 2017 Dec; 19(2):84-88. PubMed ID: 29189554
[TBL] [Abstract][Full Text] [Related]
4. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
5. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
6. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
7. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
9. Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution.
Di Lorenzo R; Mente K; Li J; Shayya L; Rae-Grant A; Li Y; Jammoul A
J Neurol; 2018 Sep; 265(9):2114-2119. PubMed ID: 29987589
[TBL] [Abstract][Full Text] [Related]
10. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
[TBL] [Abstract][Full Text] [Related]
11. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
12. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
Hajela RK; Huntoon KM; Atchison WD
Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
[TBL] [Abstract][Full Text] [Related]
13. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
14. Cancer detection after a 9-year course of Lambert-Eaton myasthenic syndrome complicated by anti-Hu associated limbic encephalitis.
Falso S; Spagni G; Iorio R; Evoli A
Neuromuscul Disord; 2023 Sep; 33(9):90-92. PubMed ID: 37507235
[TBL] [Abstract][Full Text] [Related]
15. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
16. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
[TBL] [Abstract][Full Text] [Related]
17. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
18. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
[TBL] [Abstract][Full Text] [Related]
19. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
Vincent A; Lang B; Newsom-Davis J
Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]